Agile Therapeutics Inc (AGRX) Inventory Turnover Ratio, from second quarter 2024 to second quarter 2023, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Agile Therapeutics Inc  (AGRX)
 

Agile Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2024, Agile Therapeutics Inc's inventory turnover ratio sequentially decreased to 1.63 in the second quarter 2024, unsurprisingly, as the Agile Therapeutics Inc markets continue to deteriorate, and AGRX's faces growing challenges to bring down its inventories. Agile Therapeutics Inc's average inventory processing period in the Jun 30 2024 quarter, has increased to 224 days, from 149 days, in the Mar 31 2024 quarter.

Within Healthcare sector 40 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 977 in the first quarter 2024, to 1127.

AGRX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Agile Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AGRX Inventory Turnover Ratio (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Inventory Growth 128.34 % 69.52 % 105.56 % 34.17 % 8.42 %
Y / Y Cost of Sales Growth -50 % -50.07 % 20.81 % 40.35 % -10.35 %
Inventory Turnover Ratio (TTM) 1.63 2.45 3.23 3.61 3.6
AGRX's Total Ranking # 1127 # 977 # 812 # 736 # 674
Average inventory processing period 224 149 113 101 102
Seq. Inventory Growth 54.56 % 36.89 % 13.56 % -4.97 % 14.74 %
Seq. Cost of Sales Growth 0 % -49.92 % -0.15 % 0 % -0.15 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 8
Healthcare Sector # 41
Overall Market # 1127

Inventory Turnover Ratio Statistics
High Average Low
12.7 8.5 4.92
(Sep 30 2023)   (Dec 31 2021)



AGRX Company Profile >> Back to AGRX Efficiency Comparisons >> Compare AGRX Inventory Turnover Ratio to its Competitors

Financial Statements
Agile Therapeutics Inc's Inventories $ 6 Millions Visit AGRX's Balance sheet
Agile Therapeutics Inc's Cost of Revenues TTM $ 6 Millions Visit AGRX's Income Statement
What are AGRX's Sales? Visit AGRX's Sales by Segment

Other Inventory Turnover Ratios
Agile Therapeutics Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AGRX's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AGRX's Competitors
Inventory Turnover Ratio for AGRX's Suppliers
Inventory Turnover Ratio for AGRX's Customers

You may also want to know
AGRX's Sales Growth Rates AGRX's Pe Price to earnings ratio AGRX's Receivables Turnover Ratio AGRX's Stock Quote
AGRX's Net Income Growth Rates AGRX's Ps Price to Sales ratio AGRX's Sales per Employee AGRX's Asset Turnover Ratio
AGRX's Net Margin AGRX's Pb Price to Book ratio AGRX's Financial Strength Ratios AGRX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2024 Inventories at quarter ending Jun 30 2024
Coherus Oncology inc   2.84 $ 180.224  Millions$ 63  Millions
Urogen Pharma Ltd   2.83 $ 8.610  Millions$ 3  Millions
Bluebird Bio Inc   2.80 $ 75.397  Millions$ 27  Millions
Elite Pharmaceuticals Inc   2.79 $ 36.000  Millions$ 13  Millions
Guardion Health Sciences Inc   2.74 $ 5.037  Millions$ 2  Millions
Astrotech Corp  2.74 $ 0.913  Millions$ 0  Millions
10x Genomics Inc   2.74 $ 223.081  Millions$ 82  Millions
Neogen Corporation  2.73 $ 459.167  Millions$ 168  Millions
Abbott Laboratories  2.71 $ 18,227.000  Millions$ 6,715  Millions
Telesis Bio Inc   2.71 $ 9.023  Millions$ 3  Millions
Zynex inc   2.69 $ 39.094  Millions$ 15  Millions
Camp4 Therapeutics Corporation  2.68 $ 75.000  Millions$ 28  Millions
Tarsus Pharmaceuticals Inc   2.67 $ 6.251  Millions$ 2  Millions
Lifevantage Corp  2.65 $ 41.000  Millions$ 15  Millions
Dexcom Inc   2.64 $ 1,465.200  Millions$ 554  Millions
Ardelyx inc   2.63 $ 29.333  Millions$ 11  Millions
Tandem Diabetes Care Inc   2.63 $ 405.370  Millions$ 154  Millions
Marizyme Inc   2.62 $ 0.109  Millions$ 0  Millions
Zeo Scientifix Inc   2.62 $ 0.752  Millions$ 0  Millions
International Stem Cell Corporation  2.62 $ 3.444  Millions$ 1  Millions
Evofem Biosciences Inc   2.61 $ 4.296  Millions$ 2  Millions
Aquestive Therapeutics Inc   2.58 $ 18.392  Millions$ 7  Millions
Quidelortho Corp  2.55 $ 1,477.100  Millions$ 579  Millions
Phibro Animal Health Corporation  2.55 $ 704.000  Millions$ 276  Millions
Inmed Pharmaceuticals Inc  2.54 $ 3.567  Millions$ 1  Millions
Pro dex Inc   2.54 $ 39.293  Millions$ 15  Millions
Livanova Plc  2.53 $ 389.980  Millions$ 154  Millions
Perrigo Company Plc  2.51 $ 2,837.000  Millions$ 1,132  Millions
Inspire Medical Systems inc   2.50 $ 104.860  Millions$ 42  Millions
Journey Medical Corp  2.49 $ 25.801  Millions$ 10  Millions

Date modified: 2026-08-29T17:26:59+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.